Fluoroquinolone Delayed Adverse Events Showing up In More and More Studies
Academic research is just now incidentally scratching the surface on the subject of delayed adverse events, or late fluoroquinolone effects.
Academic research is just now incidentally scratching the surface on the subject of delayed adverse events, or late fluoroquinolone effects.
Dr. Bennett at the University of South Carolina School of Medicine is conducting a study into Fluoroquinolone (FQ) genetic predispositions.
I believe that metabolomics is going to open a door for giving us insight into chronic fluoroquinolone toxicity and provide insight into treatment options for those chronically suffering.
It is this author’s opinion, that anything based on the quinoline pharmacophore synthetic or not, whose history can be traced all the way back to the cinchona tree, has a unique propensity for toxic damage in the human body.
Dr. Charles Bennett has been able to successfully publish a paper titled "Fluoroquinolone-Related Neuropsychiatric and Mitochondrial Toxicity: a collaborative investigation by scientists and members of a social network."
A interesting two part series covering our five year research relationship with Dr. Noble, U of R; In this article, part 2, he reveals troubling findings about Levaquin.
A interesting two part series covering our five year research relationship with Dr. Noble, U of R; He has assisted us with a submission for the upcoming FDA Meeting, asked us to collect data for his research, and in part 2 reveals troubling findings about Levaquin.
Dr. Beatrice Golomb, University of California San Diego, has been able to successfully publish a paper with four case reports of individuals suffering from Fluoroquinolone Toxicity.
“You can’t do what I do and think the drug companies don’t notice you.” With the media scrutiny and the Citizen Petitions filed over the last year you can bet that Bennett has gotten the attention of some very powerful entities; entities that are going to push back in an effort to silence or undermine our message.
Our FQ team will be working closely with Dr. Golomb as she takes research to the next level in the near future. Stay tuned here as I will be sure to inform the FQ community of any pertinent developments with her, along with developments with other researchers that we work with.
I have found that there is a great misconception by many, including doctors, about the concept of senescence. Most believe it is just simply ‘old age’, but its far more....
When researchers have the mindset that the current usable formulary of FQ’s is a goal to reach based on safety and efficacy then the premise of their research is flawed.
Have you taken a fluoroquinolone antibiotic such as Cipro (ciprofloxacin), Levaquin (levofloxacin), or Avelox (moxifloxacin)? Would you be willing to help in a survey-based medical research study?